Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Platelet-derived Lrg1 links lung signaling to inflammatory remodeling of the aortic wall during aortic aneurysms

ABSTRACT: Platelets are essential mediators of hemostasis, but increasing evidence shows they also function as key messengers linking distant tissues through dynamic vascular interactions. Here, we demonstrate that platelets and thrombopoiesis regulate aortic wall integrity in abdominal aortic aneurysms (AAA), a life-threatening disease marked by progressive dilation and rupture of the aorta. Aneurysmal platelets were enriched in Lrg1, which acted as a key effector coupling platelet activation to maladaptive matrix remodeling within the aortic wall. Using lineage tracing, we found that bone marrow–derived Lrg1⁺ platelets accumulated during later stages of disease, whereas lung-derived Lrg1⁺ platelets were rapidly deployed to the abdominal aorta immediately after aneurysm induction and persisted throughout AAA progression, revealing an early and sustained crosstalk axis between the lungs and the vasculature. Conditional deletion of Lrg1 in platelets, as well as lung-specific suppression of Lrg1, protected mice from AAA, demonstrating that Lrg1 is a dominant molecular mediator through which lung-derived signals drive vascular remodeling. Mechanistically, platelet-derived Lrg1 regulated cell–cell interactions within the aortic wall, promoted endothelial inflammation and extracellular-matrix degradation via a TGFBR2/NF-κB/IL-6 signaling axis. These findings demonstrate platelets as novel cellular circuits via which the lungs communicate with and modulate the vasculature.

ORGANISM(S): Homo sapiens

PROVIDER: GSE345146 | GEO | 2026/08/26

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Platelet-derived Lrg1 links lung signaling to inflammatory remodeling of the aortic wall during aortic aneurysms [CITE-Seq]

Project description:Platelets are essential mediators of hemostasis, but increasing evidence shows they also function as key messengers linking distant tissues through dynamic vascular interactions. Here, we demonstrate that platelets and thrombopoiesis regulate aortic wall integrity in abdominal aortic aneurysms (AAA), a life-threatening disease marked by progressive dilation and rupture of the aorta. Aneurysmal platelets were enriched in Lrg1, which acted as a key effector coupling platelet activation to maladaptive matrix remodeling within the aortic wall. Using lineage tracing, we found that bone marrow–derived Lrg1⁺ platelets accumulated during later stages of disease, whereas lung-derived Lrg1⁺ platelets were rapidly deployed to the abdominal aorta immediately after aneurysm induction and persisted throughout AAA progression, revealing an early and sustained crosstalk axis between the lungs and the vasculature. Conditional deletion of Lrg1 in platelets, as well as lung-specific suppression of Lrg1, protected mice from AAA, demonstrating that Lrg1 is a dominant molecular mediator through which lung-derived signals drive vascular remodeling. Mechanistically, platelet-derived Lrg1 regulated cell–cell interactions within the aortic wall, promoted endothelial inflammation and extracellular-matrix degradation via a TGFBR2/NF-κB/IL-6 signaling axis. These findings demonstrate platelets as novel cellular circuits via which the lungs communicate with and modulate the vasculature.

2026-08-25 | GSE344168 | GEO

Platelet-derived Lrg1 links lung signaling to inflammatory remodeling of the aortic wall during aortic aneurysms [scRNA-Seq]

2026-08-25 | GSE344167 | GEO

Soluble Glycoprotein VI Predicts Abdominal Aortic Aneurysm Growth Rate and is a Novel Therapeutic Target

Project description:A common feature in patients with abdominal aortic aneurysms (AAA) is the formation of a nonocclusive intraluminal thrombus (ILT) in regions of aortic dilation. Platelets are known to maintain hemostasis and propagate thrombosis through several redundant activation mechanisms, yet the role of platelet activation in the pathogenesis of AAA associated ILT is still poorly understood. Thus, we sought to investigate how platelet activation impacts the pathogenesis of AAA. Using RNA-sequencing, we identify that the platelet-associated transcripts are significantly enriched in the ILT compared to the adjacent aneurysm wall and healthy control aortas. We found that the platelet specific receptor glycoprotein VI (GPVI) is among the top enriched genes in AAA ILT and is increased on the platelet surface of AAA patients. Examination of a specific indicator of platelet activity, soluble GPVI (sGPVI), in two independent AAA patient cohorts is highly predictive of a AAA diagnosis and associates more strongly with aneurysm growth rate when compared to D-dimer in humans. Finally, intervention with the anti-GPVI antibody (JAQ1) in mice with established aneurysms blunted the progression of AAA in two independent mouse models. In conclusion, we show that levels of sGPVI in humans can predict a diagnosis of AAA and AAA growth rate, which may be critical in the identification of high-risk patients. We also identify GPVI as a novel platelet-specific AAA therapeutic target, with minimal risk of adverse bleeding complications, where none currently exist.

2024-06-22 | GSE269845 | GEO

RNA-sequencing of abdominal aortic aneurysm (AAA) and control abdominal aorta tissues

Project description:Abdominal aortic aneurysm (AAA) is a permanent segmental dilatation of the abdominal aorta, contributing to a high mortality once rupture. We performed RNA-sequencing analysis of abdominal aorta tissues from 14 participants, including seven patients with AAA and seven control individuals.

2023-12-07 | GSE183464 | GEO

Difference analysis of microRNAs in abdominal aorta of ApoE-/- AngII-induced abdominal aortic aneurysm mices

Project description:Abdominal aortic aneurysm (AAA) is a vascular disease with high incidence at present.There is no effective drug treatment. MicroRNAs(miRNAs) play a regulatory role in the occurrence and development of AAA,and miRNA therapy is a promising treatment for AAA. The purpose of this study was to explore the differential expression of miRNAs in abdominal aorta of ApoE-/- AngII-induced abdominal aortic aneurysm mices. We used miRNA array to analyze miRNA differences in abdominal aorta between mices with ApoE-/- AngII-induced abdominal aortic aneurysm and ApoE-/-.

2025-10-29 | GSE280216 | GEO

Human adventitial and medial layers from AAA aorta LC-MS/MS

Project description:Abdominal aortic aneurysm (AAA) is an asymptomatic chronic disease of the aorta and its evolution is unpredictable. Despite the existence of a number of pathological mechanisms contributing to the dilation of the human AAA wall, there is currently no specific therapy to prevent the fatal rupture of the aorta. Our objective was to identify novel mediators and/or biomarkers involved in the instability of the aortic wall that could help to prevent AAA progression.

2025-07-14 | PXD056789 | Pride

IL-27 receptor signaling regulated stress hematopoiesis drives Abdominal Aortic Aneurysm development

Project description:Abdominal Aortic Aneurysm (AAA) is a prevalent life-threatening disease, where aortic wall degradation is mediated by accumulated immune cells. Though cytokines regulate inflammation within the aorta, their contribution to AAA via distant alterations, particularly in the control of hematopoietic stem cell (HSC) differentiation remains poorly defined. Here we report a pathogenic role for the interleukin-27 receptor (IL-27R) in AAA as genetic ablation of IL-27R protects mice from the disease development, where the mitigation of AAA is associated with a blunted accumulation of myeloid cells in the aorta due to the attenuation of Ang II-induced HSC expansion. The loss of IL-27R engages transcriptional programs that promote HSCs quiescence and suppresses differentiation decreasing mature myeloid cell production and accumulation in the aorta. Our studies illuminate how a prominent vascular disease can be distantly driven by cytokine dependent regulation of bone marrow precursors.

2019-10-14 | GSE129881 | GEO

PRDM16 Deficiency in Vascular Smooth Muscle Cells Aggravates Abdominal Aortic Aneurysm

Project description:Abdominal aortic aneurysm (AAA) is usually asymptomatic until life-threatening complications occur, predominantly involving aortic rupture. Currently, no drug-based treatments are available, primarily due to limited understanding of AAA pathogenesis. The transcriptional regulator PR domain–containing protein 16 (PRDM16) is highly expressed in the aorta, but its functions in the aorta are largely unknown. By RNA-seq analysis, we found that vascular smooth muscle cell–specific (VSMC-specific) Prdm16-knockout (Prdm16SMKO) mice already showed extensive changes in the expression of genes associated with extracellular matrix (ECM) remodeling and inflammation in the abdominal aorta under normal housing conditions without any pathological stimuli. Human AAA lesions displayed lower PRDM16 expression. Periadventitial elastase application to the suprarenal region of the abdominal aorta aggravated AAA formation in Prdm16SMKO mice. During AAA development, VSMCs undergo apoptosis because of both intrinsic and environmental changes, including inflammation and ECM remodeling. Prdm16 deficiency promoted inflammation and apoptosis in VSMCs. A disintegrin and metalloproteinase 12 (ADAM12) is a gelatinase that can degrade various ECMs. We found that ADAM12 is a target of transcriptional repression by PRDM16. Adam12 knockdown reversed VSMC apoptosis induced by Prdm16 deficiency. Our study demonstrated that PRDM16 deficiency in VSMCs promoted ADAM12 expression and aggravates AAA formation, which may provide potential targets for AAA treatment.

2023-06-08 | GSE222440 | GEO

Soluble epoxide hydrolase in the liver orchestrates abdominal aortic aneurysm formation

Project description:The liver plays an important role in cardiovascular disease by amplifying systemic inflammation, while the underlying mechanisms remain to be defined. Soluble epoxide hydrolase (sEH) is a pro-inflammatory enzyme and pharmacological inhibition of sEH was shown to protect against various inflammatory diseases. In this study, we have identified a novel role of the liver, through expression of sEH, in the pathogenesis of abdominal aortic aneurysm (AAA). sEH expression and activity were markedly higher in mouse liver compared with aorta and further increased in the context of AAA. Pharmacological inhibition or hepatocyte-specific disruption of sEH prevented AAA formation in two animal models of AAA (systemic angiotensin II infusion and local aortic calcium chloride application), concomitant with reduced expression of complement C3 and serum amyloid A, liver-derived inflammatory factors causally linked to AAA formation. Interestingly, data from co-incubation of liver ex vivo with aorta identified galectin-3 secreted from the aneurysm-prone aorta that activate sEH in the liver. We also determined 12,13- dihydroxyoctadecenoic acid (DiHOME) and various circulating pro-inflammatory cytokines as a downstream mechanism potentially associated with hepatic sEH in the context of AAA. These novel findings provide direct evidence that bidirectional crosstalk between aorta and liver contributes to AAA via hepatic sEH.

2026-04-07 | PXD073197 | Pride

Single cell transcriptomics of human abdominal aortic aneurysm [scRNA-seq]

Project description:An abdominal aortic aneurysm (AAA) is a pathological widening of the aortic wall characterized by loss of AoSMCs, extracellular matrix degradation and local inflammation. This condition is often asymptomatic until rupture occurs, leading to high morbidity and mortality rates. We conducted single-cell RNA sequencing (scRNA-seq) from AAA patients´s specimens to profile gene expression at single cell level and to gain insight on cell types relevant to disease dynamics.

2023-08-30 | GSE237230 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data